Decision: Favourable

Study Title:

Real world evidence observational study to evaluate performance and safety of intravesical sodium hyaluronate (Cystistat®) in the treatment of patients with interstitial cystitis (IC)/bladder pain syndrome (BPS)

  • NREC Code:

    22-NREC-MD-017

  • Decision:

    Favourable

  • Meeting Date:

    21/07/2022

  • Study Type:

    MD application

  • Principal Investigator:

    Prof Rustom Manecksha

  • PI Institution:

    Tallaght Hospital University

  • Sponsor:

    MEDA Pharma GmbH & Co. KG (A Viatris company)

Scroll to Top